Study on the Intestinal Absorption Profiles of Tanshinone IIA and its Inclusion Complex with Cyclodextrin in Rats | PDA Journal of Pharmaceutical Science and Technology

References

↵
1. Lin H. C.,
2. Chang W. L.
Diterpenoids from Salvia miltiorrhiza. Phytochemistry 2000, 53 (8), 951–953.
OpenUrl PubMed Google Scholar
↵
1. Lin L. Z.,
2. Wang X. M.,
3. Huang X. L.,
4. Huang Y.,
5. Yang B. J.
A new diterpenoid quinone dehydromitirone. Acta Pharm. Sin. 1988, 23 (4), 273–275.
OpenUrl Google Scholar
↵
1. Li Z. T.,
2. Yang B. J.,
3. Ma G. E.
Chemical studies of Salvia miltiorrhiza f.lba. Acta Pharm. Sin. 1991, 26 (3), 209–213.
OpenUrl Google Scholar
↵
1. Tian G. L.,
2. Zhang T. Y.,
3. Zhang Y. B.,
4. Ito Y.
Separation of tanshinones from Salvia miltiorrhiza Bunge by multidimensional counter-current chromatography. J. Chromatogr., A 2002, 945 (1–2), 281–285.
OpenUrl PubMed Google Scholar
↵
1. Shi Z. H.,
2. He J. T.,
3. Chang W. B.
Micelle-mediated extraction of tanshinones from Salvia miltiorrhiza bunge with analysis by high-performance liquid chromatography. Talanta 2004, 64 (2), 401–407.
OpenUrl PubMed Google Scholar
↵
1. Tian G. L.,
2. Zhang Y. B.,
3. Zhang T. Y.,
4. Yang F. Q.,
5. Ito Y.
Separation of tanshinones from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography using stepwise elution. J. Chromatogr., A 2000, 904 (1), 107–111.
OpenUrl PubMed Google Scholar
↵
1. Arima H.,
2. Yunomae K.,
3. Miyake K.,
4. Irie T.,
5. Hirayama F.,
6. Uekama K.
Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. J. Pharm. Sci. 2001, 90 (6), 690–701.
OpenUrl PubMed Google Scholar
↵
1. Blanchard J.,
2. Ugwu S. O.,
3. Bhardwaj R.,
4. Dorr R. T.
Development and testing of an improved parenteral formulation of phenytoin using 2-hydroxypropyl-β-cyclodextrin. Pharm. Dev. Technol. 2000, 5 (3), 333–338.
OpenUrl PubMed Google Scholar
↵
1. Tian B. P.,
2. Yuan Z. F.,
3. Zhang L. T.
The review: pharmacokinetic studies in vivo for Danshen and its preparations. China Pharmacy 2003, 14 (6), 375–376.
OpenUrl Google Scholar
↵
1. Li J.,
2. Wang G. J.,
3. Li P.,
4. Hao H. P.
Simultaneous determination of tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionisation-mass spectrometry. J. Chromatogr., B 2005, 826 (1–2), 26–30.
OpenUrl Google Scholar
↵
1. Li H. L.,
2. Wang Q.,
3. He L. C.
Study on pharmacokinetics of Xinkangping. Res. Prac. Chi. Med. 2004, 18 (3), 54–56.
OpenUrl Google Scholar
↵
1. Blanco J.,
2. Vila-Jato J. L.,
3. Otero F.,
4. Aguian S.
Influence of method of preparation on inclusion complexes of naproxen with different cyclodextrin. Drug Dev. Ind. Pharm. 1991, 17 (7), 943–957.
OpenUrl Google Scholar
↵
1. Palmieri G. F.,
2. Angeli D. G.,
3. Giovannucci G.,
4. Martelli S.
Inclusion of methoxybutropate in β- and hydroxypropyl-β-cyclodextrins: Comparison of preparation methods. Drug Dev. Ind. Pharm. 1997, 23 (1), 27–37.
OpenUrl Google Scholar
↵
1. Castillo J. A,
2. Canales J. P.,
3. Garcia J. J.,
4. Lastres J. L.,
5. Bolas F.,
6. Torrado J. J.
Preparation and characterization of albendazole-β-cyclodextrin complexes. Drug Dev. Ind. Pharm. 1999, 25 (12), 1241–1248.
OpenUrl CrossRef PubMed Web of Science Google Scholar
↵
1. Cheng K. W.,
2. Li X. H.
Cyclodextrin's modification and application. J. Shenyang Ag. Univ. 2001, 32 (4), 313–316.
OpenUrl Google Scholar
↵
1. Albers E.,
2. Müller B. W.
Complexation of steroid hormones with cyclodextrin derivatives: substituent effects of the guest molecule on solubility and stability in aqueous solution. J. Pharm. Sci. 1992, 81 (8), 756–761.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Loftsson T.,
2. Brewster M. E.
Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85 (10), 1017–1025.
OpenUrl CrossRef PubMed Web of Science Google Scholar
↵
1. Hovgaard L.,
2. Brondsted H.
Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharm. Res. 1995, 12 (9), 1328–1332.
OpenUrl PubMed Google Scholar
↵
1. Fan Y. X.,
2. Li J. F.,
3. Dong C.
Preparation and study on the inclusion complexes of two tanshinone compounds with β-cyclodextrin. Spectrochim. Acta. A Mol. Biomol. Spectrosc. 2005, 61 (1–2), 135–140.
OpenUrl PubMed Google Scholar
↵
1. Yan J. H.,
2. Zhang C. P.,
3. Yang P.
A study on inclusion complexes of Hydroxypropyl-β-cyclodextrin with Tanshinone IIA. Acta Chimica. Sinica. 2006, 64 (7), 652–656.
OpenUrl Google Scholar
↵
1. Higuchi T.,
2. Connors K. A.
Phase solubility techniques. Adv. Anal. Chem. Instrum. 1965, 4, 117–212.
OpenUrl Google Scholar
↵
1. Zheng Y. Q.,
2. Qiu Y. H.,
3. Fu L. M. Y.,
4. Hoffman D.,
5. Reiland T. L.
Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats. Int. J. Pharm. 1999, 185 (1), 83–92.
OpenUrl PubMed Google Scholar
↵
1. Schurgers N.,
2. Bijdendijk J.,
3. Tukker J. J.,
4. Crommelin D. J. A.
Comparison of four experimental techniques for studying drug absorption kinetics in the anesthetized rat in situ. J. Pharm. Sci. 1986, 75 (2), 117–119.
OpenUrl PubMed Google Scholar
↵
1. Pascal L. C.,
2. Gilles D.,
3. Francois C.,
4. Roger L. V.
Influence of hydroxypropyl-β-cyclodextrin and dimethyl-β-cyclodextrin on diphenhydramine intestinal absorption in a rat in situ model. Int. J. Pharm. 1998, 169 (2), 221–228.
OpenUrl Google Scholar
↵
1. Liu T. M.,
2. Jiang X. H.
Investigation of the absorption mechanisms of baicalin and baicalein in rats. J. Pharm. Sci. 2006, 95 (6), 1326–1333.
OpenUrl CrossRef PubMed Web of Science Google Scholar
↵
1. Rama Prasad Y. V.,
2. Minamimotoa T.,
3. Yoshikawa Y.,
4. Shibata N.,
5. Mori S.,
6. Matsuura A.,
7. Takada K.
In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer. Int. J. Pharm. 2004, 271 (1–2), 225–232.
OpenUrl PubMed Google Scholar
↵
1. Manosroi J.,
2. Apriyani M. G.,
3. Foe K.,
4. Manosroi A.
Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 2005, 293 (1–2), 235–240.
OpenUrl PubMed Google Scholar
↵
1. Annaert P.,
2. Tukker J. J.,
3. van Gelder J.,
4. Naesens L.,
5. de Clercq E.,
6. van Den Mooter G.,
7. Kinget R.,
8. Augustijns P.
In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil. J. Pharm. Sci. 2000, 89 (8), 1054–1062.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Jonker C.,
2. Hamman J. H.,
3. Kotzé A. F.
Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation. Int. J. Pharm. 2002, 238 (1–2), 205–213.
OpenUrl CrossRef PubMed Web of Science Google Scholar
↵
1. Ruiz-Balaguer N.,
2. Nacher A.,
3. Casabo V. G.,
4. Sanjuan M. M.
Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes. Int. J. Pharm. 2002, 234 (1–2), 101–111.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Cabral Marques H.,
2. Hadgraft J.,
3. Kllaway I.
Studies of cyclodextrin inclusion complexes. I. The salbutamol–cyclodextrin complex as studied by phase solubility and DSC. Int. J. Pharm. 1990, 63 (3), 259–266.
OpenUrl Google Scholar
↵
1. Williams O. R., III,
2. Mahaguna V.,
3. Sriwongjanya M.
Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Biopharm. 1998, 46 (3), 355–360.
OpenUrl PubMed Google Scholar
↵
1. Esclusa-Dýaz M.,
2. Torres-Labandeira J.,
3. Kata M.,
4. Vila-Jato J.
Inclusion complexation of glibenclamide with 2-hydroxypropyl-β-cyclodextrin in solution and in solid state. Eur. J. Pharm. Sci. 1994, 1 (6), 291–296.
OpenUrl Google Scholar
↵
1. Mura P.,
2. Adragna E.,
3. Rabasco A.,
4. Moyano J.,
5. Perez-Martinez J.,
6. Arias M.,
7. Gines J.
Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems. Drug Dev. Ind. Pharm. 1999, 25 (3), 279–287.
OpenUrl PubMed Google Scholar
↵
1. Fernandes C. M.,
2. Vieira M. T.,
3. Veiga F. J. B.
Physicochemical characterization and in vitro dissolution behavior of nicardipine–cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 2002, 15 (1), 79–88.
OpenUrl PubMed Google Scholar
↵
1. Hidalgo I. J.,
2. Raub T. J.,
3. Borchardt R. T.
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96 (3), 736–749.
OpenUrl PubMed Web of Science Google Scholar
↵
1. Barthe L.,
2. Woodley J. F.,
3. Kenworthy S.,
4. Houin G.
An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur. J. Drug Metab. Pharmacokinet. 1998, 23 (3), 313–323.
OpenUrl PubMed Web of Science Google Scholar
↵
1. Shargel L.,
2. Yu A.
Applied Biopharmaceutics and Pharmacokinetics, 4th ed.; Appleton & Lange Company: Stamford, CT, 1999; pp 101–103.
Google Scholar
↵
1. Nakanishi K.,
2. Nadai T.,
3. Masada M.,
4. Miyajima K.
Effects of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins. Chem. Pharm. Bull. 1992, 40 (5), 1252–1256.
OpenUrl PubMed Google Scholar
↵
1. Frijlink H. W.,
2. Eissens A. C.,
3. Hefting N. R.,
4. Poelstra K.,
5. Lerk C. F.,
6. Meijer D. K. F.
The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Pharm. Res. 1991, 8 (1), 9–16.
OpenUrl CrossRef PubMed Google Scholar
↵
1. Sharma P.,
2. Varma M. V. S.,
3. Chawla H. P. S.,
4. Panchagnula R.
Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Il Farmaco 2005, 60 (11–12), 884–893.
OpenUrl PubMed Google Scholar